ZIVO vs. BSX
ZIVO (ZIVO Bioscience, Inc.) and BSX (Boston Scientific Corporation) are both stocks. Both are in the Healthcare sector — ZIVO in Biotechnology, BSX in Medical Devices. Over the past 10 years, ZIVO returned 27.94%/yr vs 7.11%/yr for BSX. At a 0.02 correlation, their price movements are largely independent.
Performance
ZIVO vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZIVO achieves a -50.56% return, which is significantly higher than BSX's -53.37% return. Over the past 10 years, ZIVO has outperformed BSX with an annualized return of 27.94%, while BSX has yielded a comparatively lower 7.11% annualized return.
ZIVO
- 1D
- 16.58%
- 1M
- 4.80%
- YTD
- -50.56%
- 6M
- -56.50%
- 1Y
- -69.75%
- 3Y*
- -31.39%
- 5Y*
- -30.56%
- 10Y*
- 27.94%
BSX
- 1D
- -2.50%
- 1M
- -23.05%
- YTD
- -53.37%
- 6M
- -53.75%
- 1Y
- -57.30%
- 3Y*
- -6.26%
- 5Y*
- 0.16%
- 10Y*
- 7.11%
ZIVO vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ZIVO ZIVO Bioscience, Inc. | -50.56% | -59.53% | 1,691.67% | -92.00% | -12.89% | 1,813.33% | -11.76% | 30.77% | 44.44% | -5.26% |
BSX Boston Scientific Corporation | -53.37% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between ZIVO and BSX is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.01 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Sep 24, 2012 | 0.02 |
Fundamentals
ZIVO:
$16.71M
BSX:
$66.47B
ZIVO:
-$2.58
BSX:
$2.38
ZIVO:
138.68
BSX:
3.22
ZIVO:
$119.03K
BSX:
$20.62B
ZIVO:
$39.21K
BSX:
$14.52B
ZIVO:
-$9.86M
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZIVO vs. BSX — Risk / Return Rank
ZIVO
BSX
ZIVO vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ZIVO Bioscience, Inc. (ZIVO) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZIVO | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.24 | ||
| Sortino ratioReturn per unit of downside risk | +2.81 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 0.63 | +0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.74 | -0.97 | +0.23 |
| Martin ratioReturn relative to average drawdown | -1.33 | -2.05 | +0.72 |
Loading charts...
Drawdowns
ZIVO vs. BSX - Drawdown Comparison
The maximum ZIVO drawdown since its inception was -98.52%, which is greater than BSX's maximum drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for ZIVO and BSX.
Loading charts...
Drawdown Indicators
| ZIVO | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.52% | -89.15% | -9.37% |
Max Drawdown (1Y)Largest decline over 1 year | -93.85% | -59.01% | -34.84% |
Max Drawdown (3Y)Largest decline over 3 years | -97.16% | -59.01% | -38.15% |
Max Drawdown (5Y)Largest decline over 5 years | -98.52% | -59.01% | -39.51% |
Max Drawdown (10Y)Largest decline over 10 years | -98.52% | -59.01% | -39.51% |
Current DrawdownCurrent decline from peak | -86.84% | -58.89% | -27.95% |
Average DrawdownAverage peak-to-trough decline | -63.80% | -38.77% | -25.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.27% | 27.95% | +24.32% |
Volatility
ZIVO vs. BSX - Volatility Comparison
ZIVO Bioscience, Inc. (ZIVO) has a higher volatility of 37.02% compared to Boston Scientific Corporation (BSX) at 14.77%. This indicates that ZIVO's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZIVO | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 37.02% | 14.77% | +22.25% |
Volatility (6M)Calculated over the trailing 6-month period | 139.43% | 33.13% | +106.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 174.34% | 35.15% | +139.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 139.39% | 25.83% | +113.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1,082.90% | 27.35% | +1,055.55% |
Dividends
ZIVO vs. BSX - Dividend Comparison
Neither ZIVO nor BSX has paid dividends to shareholders.
Financials
ZIVO vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between ZIVO Bioscience, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ZIVO and BSX have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZIVO has higher volatility (37.02%) compared to BSX (14.77%). In terms of maximum drawdown, ZIVO dropped -98.52% vs BSX's -89.15%.
ZIVO currently has the higher Sharpe Ratio (-0.40 vs -1.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZIVO and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer